The first successful case of ABO-incompatible living-donor lobar lung transplantation following desensitization therapy
Copyright © 2023 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved..
ABO-incompatible (ABO-I) living-donor lobar lung transplantation (LDLLT) was successfully performed in a 14-year-old girl who suffered from bronchiolitis obliterans due to graft-versus-host disease following hematopoietic stem cell transplantation. In the ABO-I LDLLT procedure, the blood type O patient received a right lower lobe donated from her blood type B father and a left lower lobe donated from her blood type O mother. Desensitization therapy, using rituximab, immunosuppressants, and plasmapheresis, was implemented for 3 weeks prior to transplantation to reduce the production of anti-B antibodies in the recipient and prevent acute antibody-mediated rejection after ABO-I LDLLT.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons - 23(2023), 9 vom: 15. Sept., Seite 1451-1454 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Nakajima, Daisuke [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
4F4X42SYQ6 |
|---|
| Anmerkungen: |
Date Completed 04.09.2023 Date Revised 15.09.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ajt.2023.04.031 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM356522032 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM356522032 | ||
| 003 | DE-627 | ||
| 005 | 20231226070637.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ajt.2023.04.031 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1188.xml |
| 035 | |a (DE-627)NLM356522032 | ||
| 035 | |a (NLM)37149042 | ||
| 035 | |a (PII)S1600-6135(23)00457-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Nakajima, Daisuke |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The first successful case of ABO-incompatible living-donor lobar lung transplantation following desensitization therapy |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.09.2023 | ||
| 500 | |a Date Revised 15.09.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a ABO-incompatible (ABO-I) living-donor lobar lung transplantation (LDLLT) was successfully performed in a 14-year-old girl who suffered from bronchiolitis obliterans due to graft-versus-host disease following hematopoietic stem cell transplantation. In the ABO-I LDLLT procedure, the blood type O patient received a right lower lobe donated from her blood type B father and a left lower lobe donated from her blood type O mother. Desensitization therapy, using rituximab, immunosuppressants, and plasmapheresis, was implemented for 3 weeks prior to transplantation to reduce the production of anti-B antibodies in the recipient and prevent acute antibody-mediated rejection after ABO-I LDLLT | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a ABO-incompatible | |
| 650 | 4 | |a desensitization | |
| 650 | 4 | |a living donor | |
| 650 | 4 | |a lung transplantation | |
| 650 | 4 | |a plasmapheresis | |
| 650 | 4 | |a rituximab | |
| 650 | 7 | |a Rituximab |2 NLM | |
| 650 | 7 | |a 4F4X42SYQ6 |2 NLM | |
| 650 | 7 | |a Immunosuppressive Agents |2 NLM | |
| 700 | 1 | |a Yuasa, Itsuki |e verfasserin |4 aut | |
| 700 | 1 | |a Kayawake, Hidenao |e verfasserin |4 aut | |
| 700 | 1 | |a Tanaka, Satona |e verfasserin |4 aut | |
| 700 | 1 | |a Yamada, Yoshito |e verfasserin |4 aut | |
| 700 | 1 | |a Yutaka, Yojiro |e verfasserin |4 aut | |
| 700 | 1 | |a Hamaji, Masatsugu |e verfasserin |4 aut | |
| 700 | 1 | |a Ohsumi, Akihiro |e verfasserin |4 aut | |
| 700 | 1 | |a Ikeda, Tadashi |e verfasserin |4 aut | |
| 700 | 1 | |a Suga, Takenori |e verfasserin |4 aut | |
| 700 | 1 | |a Baba, Shiro |e verfasserin |4 aut | |
| 700 | 1 | |a Hiramatsu, Hidefumi |e verfasserin |4 aut | |
| 700 | 1 | |a Date, Hiroshi |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons |d 2001 |g 23(2023), 9 vom: 15. Sept., Seite 1451-1454 |w (DE-627)NLM119667924 |x 1600-6143 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2023 |g number:9 |g day:15 |g month:09 |g pages:1451-1454 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ajt.2023.04.031 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2023 |e 9 |b 15 |c 09 |h 1451-1454 | ||